Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial studies computer-guided glucose management systems in treating patients with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided glucose management system may help manage glucose levels in patients who have undergone blood or bone marrow transplant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Insulin Balanced Infusion System

NCT01291719

Hyperglycemia Diabetes

ACTIVE_NOT_RECRUITING PHASE1/PHASE2

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

NCT02012465

Lymphoma Diabetes Mellitus, Type 2 Hyperglycemia

COMPLETED EARLY_PHASE1

Glycemic Impact on Glioblastoma Outcomes

NCT03235934

Glioblastoma Multiforme Hyperglycemia

WITHDRAWN

Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT

NCT06909071

T2DM Patients With Traumatic Brain Injury

RECRUITING NA

Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy

NCT02155374

Hyperglycemia Steroid-induced

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To examine the ability of computer-guided glucose management system (CGGMS) algorithms to control glucose within or close to current University of Washington Medical Center (UWMC) intensive care unit (ICU) targets (100 to 140 mg/dl) in non-critically ill bone marrow transplant (BMT) adult (age \>= 18 years) patients.

OUTLINE:

Patients receive blood glucose management with intravenous (IV) insulin using Glucommander.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperglycemia Malignant Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supportive care (Glucommander)

Patients receive blood glucose management with IV insulin using Glucommander.

Group Type EXPERIMENTAL

computer-assisted intervention

Intervention Type OTHER

Undergo blood glucose management using Glucommander

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

computer-assisted intervention

Undergo blood glucose management using Glucommander

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Post-transplant adult patients (age \>= 18 years) on the BMT Service at UWMC
* Requiring insulin secondary to:

* Known history of (h/o) type 2 diabetes mellitus
* Two blood sugar values \> 180 (point of care and/or am lab glycemia)
* One blood sugar value \> 250 (point of care or AM lab glycemia)

Exclusion Criteria

* Critically ill patients (intensive care unit \[ICU\] admissions)
* Terminally ill patients
* Eastern Cooperative Oncology Group (ECOG) performance status \> 3
* Previous type 1 diabetes mellitus
* Cognitively impaired patients, unable to consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No